Tennessee Senate Bill SB1947

Tennessee 2025-2026 Regular Session

• Introduced: 1/21/26
• Engrossed: 2/26/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 68, Chapter 32, relative to blood donations.

Impact

The enactment of SB1947 will directly impact the operations of blood banks and hospitals within Tennessee. By mandating that hospitals allow patients to make autologous or directed donations, the bill is expected to promote patient autonomy and potentially improve blood availability for surgical procedures. The requirement for blood banks to comply with physician orders enhances the relationship between healthcare providers and patients, ensuring that the blood donation process is more patient-centered.

Summary

Senate Bill 1947 aims to amend the Tennessee Code Annotated regarding blood donations, specifically introducing definitions and guidelines for autologous and directed blood donations. Under this bill, blood banks are required to comply with physician orders for both types of donations, ensuring they adhere to federal and state safety standards. The bill stipulates that a blood bank may charge reasonable fees for facilitating these donations, but it does not compromise existing safety or testing requirements.

Sentiment

Discussions surrounding SB1947 reflect a generally positive sentiment among healthcare professionals who support the idea of allowing more personalized blood donation options. Advocates argue that this bill will empower patients and improve their healthcare experiences. However, there are concerns regarding the feasibility of implementation across all blood banks, particularly regarding ensuring that all safety protocols remain efficiently followed amidst these new provisions.

Contention

While SB1947 aims to enhance patient choices, points of contention include the balance between increasing donation opportunities and maintaining strict safety standards. Some health professionals have raised concerns that the added responsibilities placed on blood banks and hospitals might lead to operational challenges or increased costs, which could affect their overall ability to provide safe blood products. Additionally, the stipulation for hospitals to only refuse donations under medically contraindicated circumstances needs careful monitoring to prevent misuse.